Maternal acute respiratory infectious diseases during pregnancy and birth outcomes

Ferenc Bánhidy1, Nándor Acs, Erzsébet H Puhó

  • 1Second Department of Obstetrics and Gynecology, School of Medicine, Semmelweis University, Budapest, Hungary.

The objective of the study was to evaluate the possible association between maternal acute respiratory infectious diseases (ARID) during pregnancy and birth outcomes. Newborn infants born to mothers with or without ARID as reference were compared in the population-based large data set of newborns without any defect in the Hungarian Case-Control Surveillance System of Congenital Abnormalities. Main outcome measures were birth weight and gestational age at delivery, in addition the rate of preterm births and low birthweight newborns. Of 38,151 newborns, 3,455 (9.1%) had mothers with ARID during pregnancy which were differentiated according to six manifestations from sinusitis to the pneumonia. Mothers with ARID in pregnancy had a longer (0.3 week) gestational age at delivery (adjusted t = 5.4; p < 0.0001) and a lower rate of preterm births (6.7% vs. 9.4%) [adjusted odds ratio (OR) with 95% confidence interval (CI): 0.72, 0.63-0.83] than mothers without ARID. However, severe ARID (bronchitis-bronchiolitis and particularly pneumonia) associated with a higher rate of preterm births (13.0%, adjusted OR with 95% CI: 1.4, 1.1-1.8), while mild ARID (sinusitis, pharyngitis, tonsillitis, laryngitis-tracheitis) resulted in a lower rate of preterm births (5.5%, adjusted OR with 95% CI: 0.5, 0.4-0.7). In conclusion, there was an obvious correlation between severity of ARID in pregnant women and rate of preterm births.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...